ALICE BLACKLEY: Open Payments
NPI 1124862669 · LOCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 31 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| PFIZER INC. | 3 | $58 |
| Novo Nordisk Inc | 3 | $58 |
| Abbott Laboratories | 2 | $57 |
| Lilly USA, LLC | 2 | $37 |
| Edwards Lifesciences Corporation | 1 | $35 |
| ABBVIE INC. | 1 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: AIRSUPRA, CAPLYTA, FREESTYLE LIBRE 3, SHINGRIX, Ozempic, TRELEGY ELLIPTA, QULIPTA, BREZTRI.
Industry payments across NY — which companies pay providers there.
